Risks after treatment for cervical neoplasia have declined over time

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainThe treatment of serious prodromal cervical cancer, CIN3, can cause problems during later pregnancy amongst women of fertile age. A new re

Updated on: March 23,2024

Risks after treatment for cervical neoplasia have declined over time

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainThe treatment of serious prodromal cervical cancer, CIN3, can cause problems during later pregnancy amongst women of fertile age. A new re

Updated on:March 23,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024

Protein spheres protect the genome of cancer cells

byUniversity of WürzburgMYC proteins are colored green in this figure. In normally growing cells, they are homogeneously distributed in the cell nucleus (left). In diverse stress situations, as

Updated on: December 20,2023

Protein spheres protect the genome of cancer cells

byUniversity of WürzburgMYC proteins are colored green in this figure. In normally growing cells, they are homogeneously distributed in the cell nucleus (left). In diverse stress situations, as

Updated on:December 20,2023

Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

by James MacKillop,The ConversationCredit: RDNE Stock project from PexelsBy now, most are familiar with the idea of Dry January, a voluntary month without alcohol that follows a month when many

Updated on: March 26,2024

Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

by James MacKillop,The ConversationCredit: RDNE Stock project from PexelsBy now, most are familiar with the idea of Dry January, a voluntary month without alcohol that follows a month when many

Updated on:March 26,2024

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Updated on: January 07,2024

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Updated on:January 07,2024

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on: December 25,2023

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on:December 25,2023

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve

Updated on: February 20,2024

Researchers identify protein with DYRK1A-inhibiting effect that may have implications for Down syndrome

by Kyoto UniversityDYRK1A bound to FAM53C in the cytoplasm is less active. DYRK1A not bound to FAM53C in the nucleus is highly active. Functional abnormalities cause various neuropsychiatric deve

Updated on:February 20,2024

Investigating the most allergen-inducing drugs

by Scientific Project LomonosovComparison of % of spontaneous reports (SRs) with data on drug-induced anaphylaxis (SRsAs) due to a specific pharmacological group among the total SRsAs structure and %

Updated on: May 06,2024

Investigating the most allergen-inducing drugs

by Scientific Project LomonosovComparison of % of spontaneous reports (SRs) with data on drug-induced anaphylaxis (SRsAs) due to a specific pharmacological group among the total SRsAs structure and %

Updated on:May 06,2024

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on: July 17,2024

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on:July 17,2024

Understanding breast cancer recurrence, metastatic spread

byUniversity of CincinnatiCredit: Unsplash/CC0 Public DomainDespite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researc

Updated on: December 28,2023

Understanding breast cancer recurrence, metastatic spread

byUniversity of CincinnatiCredit: Unsplash/CC0 Public DomainDespite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researc

Updated on:December 28,2023

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on: November 10,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on:November 10,2024

Chemically 'poisoned' protein acts as a molecular switch to spur cancer formation

byThe Scripps Research InstituteResearchers discovered that when the protein DNMT3B becomes S-nitrosylated in the presence of nitric oxide (NO), cancer-related genes become activated, leading to

Updated on: December 25,2023

Chemically 'poisoned' protein acts as a molecular switch to spur cancer formation

byThe Scripps Research InstituteResearchers discovered that when the protein DNMT3B becomes S-nitrosylated in the presence of nitric oxide (NO), cancer-related genes become activated, leading to

Updated on:December 25,2023